Trial Outcomes & Findings for A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome (NCT NCT00391872)
NCT ID: NCT00391872
Last Updated: 2012-03-13
Results Overview
Participants with death from vascular causes, MI, or stroke. If no event, censoring occurs at the earliest of patient withdrawal consent or date of scheduled withdrawal from therapy. Intention To Treat (ITT) analysis of whole population. Events were adjudicated by an endpoint committee.
COMPLETED
PHASE3
18624 participants
Randomization up to 12 months
2012-03-13
Participant Flow
The first participant was enrolled on 11 October 2006 and the last participant completed the study on 27 February 2009. Study participants were randomized from 855 centers in 43 countries.
Participants will already be hospitalized due to their acute condition, and must be enrolled and randomized within 24 hours of the onset of their most recent cardiac ischemic symptoms. Randomization should take place as soon as possible after presentation.
Participant milestones
| Measure |
TICAGRELOR
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Overall Study
STARTED
|
9333
|
9291
|
|
Overall Study
COMPLETED
|
9026
|
9036
|
|
Overall Study
NOT COMPLETED
|
307
|
255
|
Reasons for withdrawal
| Measure |
TICAGRELOR
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Overall Study
Protocol Violation
|
7
|
2
|
|
Overall Study
Withdrawal by Subject
|
296
|
249
|
|
Overall Study
Reason unknown
|
2
|
4
|
|
Overall Study
Lost to Follow-up
|
2
|
0
|
Baseline Characteristics
A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome
Baseline characteristics by cohort
| Measure |
TICAGRELOR
n=9333 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9291 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
Total
n=18624 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age Continuous
|
62.1 years
STANDARD_DEVIATION 11.21 • n=5 Participants
|
62.3 years
STANDARD_DEVIATION 11.21 • n=7 Participants
|
62.2 years
STANDARD_DEVIATION 22.42 • n=5 Participants
|
|
Sex: Female, Male
Female
|
2655 Participants
n=5 Participants
|
2633 Participants
n=7 Participants
|
5288 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6678 Participants
n=5 Participants
|
6658 Participants
n=7 Participants
|
13336 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Randomization up to 12 monthsPopulation: The population was the full analysis set, which included all randomized patients
Participants with death from vascular causes, MI, or stroke. If no event, censoring occurs at the earliest of patient withdrawal consent or date of scheduled withdrawal from therapy. Intention To Treat (ITT) analysis of whole population. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9333 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9291 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Any Event From the Composite of Death From Vascular Causes, Myocardial Infarction (MI), and Stroke
|
864 Participants
|
1014 Participants
|
PRIMARY outcome
Timeframe: First dosing up to 12 monthsPopulation: The population was the safety analysis set, which included all randomized patients who took at least one dose of study drug
Participants with major (fatal/life-threatening or other) bleed by a study protocol scale based on need for treatment, number of transfusions, hemoglobin decrease, and other factors. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9235 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9186 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Any Major Bleeding Event
|
961 Participants
|
929 Participants
|
SECONDARY outcome
Timeframe: Randomization up to 12 monthsPopulation: The subgroup of patients with intent for invasive management at randomization
Participants with death from vascular causes, MI, or stroke. If no event, censoring occurs at the earliest of patient withdrawal consent or date of scheduled withdrawal from therapy. ITT analysis of intent for invasive management population. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=6732 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=6676 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Any Event From the Composite of Death From Vascular Causes, MI, and Stroke for the Subgroup of Patients With Intent for Invasive Management at Randomization
|
569 Participants
|
668 Participants
|
SECONDARY outcome
Timeframe: Randomization up to 12 monthsPopulation: The population was the full analysis set, which included all randomized patients
Participants with death from any cause, MI, or stroke. If no event, censoring occurs at the earliest of patient withdrawal of consent or date of scheduled withdrawal from therapy. ITT analysis of whole population. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9333 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9291 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Any Event From the Composite of All-cause Mortality, MI, and Stroke
|
901 Participants
|
1065 Participants
|
SECONDARY outcome
Timeframe: Randomization up to 12 monthsPopulation: The population was the full analysis set, which included all randomized patients
Participants with death from vascular causes, MI, stroke, recurrent ischemia, or other thrombotic events. If no event, censoring occurs at the earliest of patient withdrawal consent or date of scheduled withdrawal from therapy. ITT analysis of whole population. Events were adjudicated.
Outcome measures
| Measure |
TICAGRELOR
n=9333 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9291 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Any Event From the Composite of Death From Vascular Causes, MI (Including Silent), Stroke, Recurrent Ischemia, Transient Ischemic Attack (TIA) and Other Arterial Thrombotic Events.
|
1290 Participants
|
1456 Participants
|
SECONDARY outcome
Timeframe: Randomization up to 12 monthsPopulation: The population was the full analysis set, which included all randomized patients
Participants with MI event. If no event, censoring occurs at the earliest of patient withdrawal consent or date of scheduled withdrawal from therapy. ITT (intention to treat) analysis of whole population. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9333 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9291 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With MI Event
|
504 Participants
|
593 Participants
|
SECONDARY outcome
Timeframe: Randomization up to 12 monthsPopulation: The population was the full analysis set, which included all randomized patients
Participants with death from vascular causes. If no event, censoring occurs at the earliest of patient withdrawal consent or date of scheduled withdrawal from therapy. ITT (intention to treat) analysis of whole population. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9333 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9291 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Death From Vascular Causes
|
353 Participants
|
442 Participants
|
SECONDARY outcome
Timeframe: Randomization up to 12 monthsPopulation: The population was the full analysis set, which included all randomized patients
Participants with stroke. If no event, censoring occurs at the earliest of patient withdrawal consent or date of scheduled withdrawal from therapy. ITT (intention to treat) analysis of whole population. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9333 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9291 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Stroke
|
125 Participants
|
106 Participants
|
SECONDARY outcome
Timeframe: Randomization up to 12 monthsPopulation: The population was the full analysis set, which included all randomized patients
Participants with death from any cause. If no event, censoring occurs at the earliest of patient withdrawal consent or date of scheduled withdrawal from therapy. ITT (intention to treat) analysis of whole population. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9333 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9291 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Death From Any Cause
|
399 Participants
|
506 Participants
|
SECONDARY outcome
Timeframe: First dosing up to 12 monthsPopulation: The population was the safety analysis set, which included all randomized patients who took at least one dose of study drug
Participants with non CABG related major (fatal/life-threatening or other) bleed by a study protocol scale based on need for treatment, number of transfusions, hemoglobin decrease, and other factors. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9235 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9186 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Non-CABG (Coronary Artery Bypass Graft) Related Major Bleeding
|
362 Participants
|
306 Participants
|
SECONDARY outcome
Timeframe: First dosing up to 12 monthsPopulation: The population was the safety analysis set, which included all randomized patients who took at least one dose of study drug
Participants with major (fatal/life-threatening or other) or minor bleed by a study protocol scale based on need for treatment, number of transfusions, hemoglobin decrease, and other factors. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9235 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9186 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Major or Minor Bleeding
|
1339 Participants
|
1215 Participants
|
SECONDARY outcome
Timeframe: First dosing up to 12 monthsPopulation: The population was the safety analysis set, which included all randomized patients who took at least one dose of study drug
Participants with non-procedural major bleed by a study protocol scale based on need for treatment, number of transfusions, hemoglobin decrease, and other factors. Events were adjudicated by an endpoint committee.
Outcome measures
| Measure |
TICAGRELOR
n=9235 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=9186 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Non-procedural Major Bleeding
|
235 Participants
|
180 Participants
|
SECONDARY outcome
Timeframe: First dosing up to 12 monthsPopulation: Population is all patients who underwent CABG surgery within 7 days of last dose of active study medication.
Participants with a major CABG-related bleed by a study protocol scale based on need for treatment, number of transfusions, hemoglobin decrease, and other factors. All CABG surgeries were submitted for adjudication by an endpoint committee as potential bleeds.
Outcome measures
| Measure |
TICAGRELOR
n=770 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=814 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Coronary Artery Bypass Graft (CABG) Major Bleeding
|
619 Participants
|
654 Participants
|
SECONDARY outcome
Timeframe: First dosing up to 12 monthsPopulation: Population is all patients who underwent CABG surgery within 7 days of last dose of active study medication.
Number of participants with a major fatal/life-threatening CABG-related bleed by a study protocol scale based on need for treatment, number of transfusions, hemoglobin decrease, and other factors. All CABG surgeries were submitted for adjudication by an endpoint committee as potential bleeds.
Outcome measures
| Measure |
TICAGRELOR
n=770 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=814 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Coronary Artery Bypass Graft (CABG) Major Fatal/Life-threatening Bleeding
|
329 Participants
|
341 Participants
|
SECONDARY outcome
Timeframe: 1-week period following randomizationPopulation: Participants with Holter data in the week after Randomization
Number of participants who were observed to have at least 1 ventricular pause of at least 3 seconds. Population is all patients who were observed over 2 week-long periods. Pauses were flagged algorithmically and confirmed by Thrombolysis in Myocardial Infarction (TIMI) group cardiologists.
Outcome measures
| Measure |
TICAGRELOR
n=1451 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=1415 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Ventricular Pauses of Greater Than or Equal to 3 Seconds in Patients Monitored by Holter 24-hour ECG Recorders for 1 Week Following Randomization
|
84 Participants
|
51 Participants
|
SECONDARY outcome
Timeframe: 1-week period following randomizationPopulation: Patients who were monitored for one week following randomization (and for one week one month later).
Number of participants who were observed to have at least 1 ventricular pause of at least 3 seconds. Population is all patients who were observed over 2 week-long periods. Pauses were flagged algorithmically and confirmed by TIMI cardiologists.
Outcome measures
| Measure |
TICAGRELOR
n=964 Participants
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
n=985 Participants
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Participants With Ventricular Pauses of Greater Than or Equal to 3 Seconds in Patients Monitored by Holter 24 Hour ECG Recorders for 1 Week at 1 Month Following Randomization
|
21 Participants
|
16 Participants
|
Adverse Events
TICAGRELOR
CLOPIDOGREL
Serious adverse events
| Measure |
TICAGRELOR
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Injury, poisoning and procedural complications
Joint Dislocation
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Joint Injury
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Spinal Compression Fracture
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Stent Occlusion
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Traumatic Haemorrhage
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Upper Limb Fracture
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Vascular Graft Occlusion
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Anaemia Postoperative
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Ankle Fracture
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Brain Contusion
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Cardiac Pacemaker Malfunction
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Cardiac Procedure Complication
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Chest Injury
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Contrast Media Reaction
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Contusion
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Coronary Artery Reocclusion
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Device Breakage
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Device Dislocation
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Device Malfunction
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Device Migration
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Fat Embolism
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Forearm Fracture
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Fracture
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Fractured Ischium
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Implantable Defibrillator Malfunction
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Incision Site Haemorrhage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Incisional Hernia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Joint Sprain
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Lumbar Vertebral Fracture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Meniscus Lesion
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Open Wound
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Pelvic Fracture
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Post Procedural Haematuria
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Procedural Complication
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Radius Fracture
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Rib Fracture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Road Traffic Accident
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Scrotal Haematoma
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Suture Rupture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Tendon Rupture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Thermal Burn
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Tibia Fracture
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Tracheal Haemorrhage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Tracheal Obstruction
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Transfusion Reaction
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Traumatic Intracranial Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Ulna Fracture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Urinary Bladder Rupture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Urinary Retention Postoperative
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Vascular Procedure Complication
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Vascular Pseudoaneurysm Ruptured
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Vertebral Injury
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Weaning Failure
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Wound Complication
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Haemoglobin Decreased
|
0.06%
6/9333
|
0.09%
8/9291
|
|
Injury, poisoning and procedural complications
Aspartate Aminotransferase Increased
|
0.01%
1/9333
|
0.04%
4/9291
|
|
Injury, poisoning and procedural complications
Alanine Aminotransferase Increased
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Injury, poisoning and procedural complications
Blood Pressure Increased
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Injury, poisoning and procedural complications
Liver Function Test Abnormal
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Injury, poisoning and procedural complications
Angiogram
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Blood Glucose Increased
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Blood Potassium Increased
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Body Temperature Increased
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Hepatic Enzyme Increased
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
International Normalised Ratio Increased
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Troponin Increased
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Antiphospholipid Antibodies
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Blood Creatine Phosphokinase Increased
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Blood Creatinine Increased
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Blood Potassium Decreased
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Blood Pressure Decreased
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Blood Sodium Decreased
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Blood Urine Present
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
C-Reactive Protein Increased
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Cardiac Enzymes Increased
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Cardiac Stress Test Abnormal
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Electrocardiogram Qt Prolonged
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Electrocardiogram T Wave Inversion
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Fibrin D Dimer Increased
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Heart Rate Increased
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Intraocular Pressure Increased
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Occult Blood
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Pancreatic Enzymes Increased
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Platelet Count Decreased
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Prostatic Specific Antigen Abnormal
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Prostatic Specific Antigen Increased
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Weight Decreased
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Metabolism and nutrition disorders
Dehydration
|
0.12%
11/9333
|
0.05%
5/9291
|
|
Metabolism and nutrition disorders
Hypoglycaemia
|
0.12%
11/9333
|
0.09%
8/9291
|
|
Metabolism and nutrition disorders
Diabetes Mellitus Inadequate Control
|
0.03%
3/9333
|
0.10%
9/9291
|
|
Metabolism and nutrition disorders
Diabetes Mellitus
|
0.06%
6/9333
|
0.08%
7/9291
|
|
Metabolism and nutrition disorders
Hyperglycaemia
|
0.08%
7/9333
|
0.02%
2/9291
|
|
Infections and infestations
Orchitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Metabolism and nutrition disorders
Hyperkalaemia
|
0.01%
1/9333
|
0.04%
4/9291
|
|
Metabolism and nutrition disorders
Anorexia
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Metabolism and nutrition disorders
Hyponatraemia
|
0.03%
3/9333
|
0.01%
1/9291
|
|
Metabolism and nutrition disorders
Diabetic Ketoacidosis
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Metabolism and nutrition disorders
Fluid Overload
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Metabolism and nutrition disorders
Gout
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Metabolism and nutrition disorders
Metabolic Acidosis
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Metabolism and nutrition disorders
Metabolic Disorder
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Metabolism and nutrition disorders
Type 2 Diabetes Mellitus
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Metabolism and nutrition disorders
Diabetic Foot
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Bursitis
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Metabolism and nutrition disorders
Electrolyte Depletion
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Metabolism and nutrition disorders
Failure To Thrive
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Metabolism and nutrition disorders
Hyperosmolar State
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Metabolism and nutrition disorders
Hypokalaemia
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Metabolism and nutrition disorders
Hypovolaemia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Metabolism and nutrition disorders
Ketoacidosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Metabolism and nutrition disorders
Metabolic Syndrome
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal Chest Pain
|
0.16%
15/9333
|
0.17%
16/9291
|
|
Musculoskeletal and connective tissue disorders
Osteoarthritis
|
0.08%
7/9333
|
0.05%
5/9291
|
|
Musculoskeletal and connective tissue disorders
Back Pain
|
0.03%
3/9333
|
0.06%
6/9291
|
|
Musculoskeletal and connective tissue disorders
Musculoskeletal Pain
|
0.05%
5/9333
|
0.04%
4/9291
|
|
Musculoskeletal and connective tissue disorders
Arthralgia
|
0.03%
3/9333
|
0.04%
4/9291
|
|
Musculoskeletal and connective tissue disorders
Myalgia
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Musculoskeletal and connective tissue disorders
Pain In Extremity
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Musculoskeletal and connective tissue disorders
Arthritis
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Musculoskeletal and connective tissue disorders
Bone Pain
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Musculoskeletal and connective tissue disorders
Costochondritis
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Gouty Arthritis
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Myalgia Intercostal
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Neck Pain
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Musculoskeletal and connective tissue disorders
Chondropathy
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Dupuytren's Contracture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Groin Pain
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Intervertebral Disc Degeneration
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Intervertebral Disc Disorder
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Central Nervous System Lesion
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Cerebellar Infarction
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Intervertebral Disc Protrusion
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Joint Swelling
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Lumbar Spinal Stenosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Monarthritis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Muscle Tightness
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Muscular Weakness
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Myositis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Osteochondrosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Osteolysis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Osteoporosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Pain In Jaw
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Pathological Fracture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Polyarthritis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Polymyalgia Rheumatica
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Polymyositis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Rhabdomyolysis
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Rheumatoid Arthritis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Spinal Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Musculoskeletal and connective tissue disorders
Spinal Osteoarthritis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Musculoskeletal and connective tissue disorders
Wrist Deformity
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Bacterial Infection
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Blood and lymphatic system disorders
Anaemia
|
0.38%
35/9333
|
0.27%
25/9291
|
|
Blood and lymphatic system disorders
Thrombocytopenia
|
0.08%
7/9333
|
0.09%
8/9291
|
|
Blood and lymphatic system disorders
Iron Deficiency Anaemia
|
0.02%
2/9333
|
0.06%
6/9291
|
|
Blood and lymphatic system disorders
Leukopenia
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Blood and lymphatic system disorders
Lymphadenitis
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Microcytic Anaemia
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Blood and lymphatic system disorders
Spontaneous Haematoma
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Coagulopathy
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Disseminated Intravascular Coagulation
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Blood and lymphatic system disorders
Granulocytopenia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Haemorrhagic Anaemia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Hypochromic Anaemia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Leukocytosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Blood and lymphatic system disorders
Lymphadenopathy
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Blood and lymphatic system disorders
Nephrogenic Anaemia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Neutropenia
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Blood and lymphatic system disorders
Normochromic Normocytic Anaemia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Pancytopenia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Polycythaemia
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Blood and lymphatic system disorders
Splenic Lesion
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Blood and lymphatic system disorders
Thrombocythaemia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Cardiac Failure
|
1.3%
122/9333
|
1.4%
129/9291
|
|
Cardiac disorders
Atrial Fibrillation
|
0.75%
70/9333
|
0.73%
68/9291
|
|
Cardiac disorders
Cardiogenic Shock
|
0.64%
60/9333
|
0.71%
66/9291
|
|
Cardiac disorders
Ventricular Fibrillation
|
0.51%
48/9333
|
0.69%
64/9291
|
|
Cardiac disorders
Cardiac Failure Congestive
|
0.55%
51/9333
|
0.50%
46/9291
|
|
Cardiac disorders
Cardiac Arrest
|
0.41%
38/9333
|
0.47%
44/9291
|
|
Cardiac disorders
Ventricular Tachycardia
|
0.31%
29/9333
|
0.36%
33/9291
|
|
Cardiac disorders
Bradycardia
|
0.28%
26/9333
|
0.33%
31/9291
|
|
Cardiac disorders
Atrioventricular Block Complete
|
0.20%
19/9333
|
0.20%
19/9291
|
|
Cardiac disorders
Cardiac Failure Acute
|
0.19%
18/9333
|
0.19%
18/9291
|
|
Cardiac disorders
Cardiac Tamponade
|
0.12%
11/9333
|
0.17%
16/9291
|
|
Cardiac disorders
Intracardiac Thrombus
|
0.14%
13/9333
|
0.16%
15/9291
|
|
Cardiac disorders
Angina Pectoris
|
0.08%
7/9333
|
0.15%
14/9291
|
|
Cardiac disorders
Cardio-Respiratory Arrest
|
0.09%
8/9333
|
0.13%
12/9291
|
|
Cardiac disorders
Atrial Flutter
|
0.12%
11/9333
|
0.08%
7/9291
|
|
Cardiac disorders
Left Ventricular Failure
|
0.11%
10/9333
|
0.05%
5/9291
|
|
Cardiac disorders
Pericardial Effusion
|
0.10%
9/9333
|
0.11%
10/9291
|
|
Cardiac disorders
Arrhythmia
|
0.09%
8/9333
|
0.04%
4/9291
|
|
Cardiac disorders
Palpitations
|
0.09%
8/9333
|
0.08%
7/9291
|
|
Cardiac disorders
Pericarditis
|
0.06%
6/9333
|
0.09%
8/9291
|
|
Cardiac disorders
Supraventricular Tachycardia
|
0.09%
8/9333
|
0.09%
8/9291
|
|
Cardiac disorders
Sick Sinus Syndrome
|
0.08%
7/9333
|
0.02%
2/9291
|
|
Cardiac disorders
Cardiac Asthma
|
0.03%
3/9333
|
0.06%
6/9291
|
|
Cardiac disorders
Mitral Valve Incompetence
|
0.04%
4/9333
|
0.06%
6/9291
|
|
Cardiac disorders
Ventricular Arrhythmia
|
0.03%
3/9333
|
0.06%
6/9291
|
|
Cardiac disorders
Ventricular Extrasystoles
|
0.06%
6/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Atrioventricular Block
|
0.03%
3/9333
|
0.05%
5/9291
|
|
Cardiac disorders
Cardiac Failure Chronic
|
0.05%
5/9333
|
0.02%
2/9291
|
|
Cardiac disorders
Coronary Artery Disease
|
0.05%
5/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Coronary Artery Dissection
|
0.05%
5/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Atrioventricular Block Second Degree
|
0.04%
4/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Electromechanical Dissociation
|
0.03%
3/9333
|
0.04%
4/9291
|
|
Cardiac disorders
Myocardial Rupture
|
0.02%
2/9333
|
0.04%
4/9291
|
|
Cardiac disorders
Sinus Bradycardia
|
0.01%
1/9333
|
0.04%
4/9291
|
|
Cardiac disorders
Tachyarrhythmia
|
0.04%
4/9333
|
0.04%
4/9291
|
|
Cardiac disorders
Tachycardia
|
0.01%
1/9333
|
0.04%
4/9291
|
|
Cardiac disorders
Acute Left Ventricular Failure
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Cardiac disorders
Aortic Valve Stenosis
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Atrial Tachycardia
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Bradyarrhythmia
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Cardiac Aneurysm
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Cardiomyopathy
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Coronary Artery Perforation
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Coronary Artery Thrombosis
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Dressler's Syndrome
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Left Ventricular Dysfunction
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Pericardial Haemorrhage
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Cardiac disorders
Sinus Arrest
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Cardiac disorders
Ventricle Rupture
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Infections and infestations
Breast Abscess
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Arrhythmia Supraventricular
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Cardiac disorders
Arteriosclerosis Coronary Artery
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Cardiac disorders
Cardiopulmonary Failure
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Cardiac disorders
Coronary Artery Occlusion
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Cardiac disorders
Coronary Artery Stenosis
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Nodal Rhythm
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Cardiac disorders
Papillary Muscle Rupture
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Right Ventricular Failure
|
0.02%
2/9333
|
0.01%
1/9291
|
|
General disorders
Inflammation Of Wound
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Acute Coronary Syndrome
|
0.01%
1/9333
|
0.01%
1/9291
|
|
General disorders
Injection Site Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Arteriospasm Coronary
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Atrial Rupture
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Bundle Branch Block
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Bundle Branch Block Left
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Cardiac Disorder
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Cardiac Valve Disease
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Cardiovascular Disorder
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Chordae Tendinae Rupture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Coronary Artery Insufficiency
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Cyanosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Dissecting Coronary Artery Aneurysm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Extrasystoles
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Hypertrophic Cardiomyopathy
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Interventricular Septum Rupture
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Ischaemic Cardiomyopathy
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Long Qt Syndrome
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Low Cardiac Output Syndrome
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Myocardial Infarction
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Myocardial Ischaemia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Myocarditis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Cardiac disorders
Papillary Muscle Disorder
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Stress Cardiomyopathy
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Torsade De Pointes
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Ventricular Dysfunction
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Cardiac disorders
Ventricular Tachyarrhythmia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Congenital, familial and genetic disorders
Carbohydrate Metabolism Disorder
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Congenital, familial and genetic disorders
Diverticulitis Meckel's
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Congenital, familial and genetic disorders
Gastrointestinal Angiodysplasia Haemorrhagic
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Congenital, familial and genetic disorders
Haemorrhagic Arteriovenous Malformation
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Congenital, familial and genetic disorders
Ventricular Septal Defect
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Ear and labyrinth disorders
Vertigo
|
0.09%
8/9333
|
0.05%
5/9291
|
|
Ear and labyrinth disorders
Vestibular Neuronitis
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Ear and labyrinth disorders
Hypoacusis
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Ear and labyrinth disorders
Deafness
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Ear and labyrinth disorders
Sudden Hearing Loss
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Ear and labyrinth disorders
Tinnitus
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Ear and labyrinth disorders
Vertigo Positional
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Endocrine disorders
Hyperthyroidism
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Endocrine disorders
Goitre
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Endocrine disorders
Pituitary-Dependent Cushing's Syndrome
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Endocrine disorders
Thyrotoxic Crisis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Eye disorders
Cataract
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Eye disorders
Diplopia
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Eye disorders
Retinal Detachment
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Eye disorders
Amaurosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Eye disorders
Amaurosis Fugax
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Eye disorders
Blindness
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Eye disorders
Cataract Nuclear
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Eye disorders
Chorioretinitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Eye disorders
Conjunctival Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Eye disorders
Diabetic Retinopathy
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Eye disorders
Eye Haemorrhage
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Eye disorders
Glaucoma
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Eye disorders
Macular Degeneration
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Eye disorders
Posterior Capsule Opacification
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Eye disorders
Retinal Artery Embolism
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Eye disorders
Visual Impairment
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Eye disorders
Vitreous Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Gastrointestinal Haemorrhage
|
0.48%
45/9333
|
0.45%
42/9291
|
|
Gastrointestinal disorders
Abdominal Pain
|
0.23%
21/9333
|
0.11%
10/9291
|
|
Gastrointestinal disorders
Abdominal Pain Upper
|
0.10%
9/9333
|
0.16%
15/9291
|
|
Gastrointestinal disorders
Diarrhoea
|
0.13%
12/9333
|
0.10%
9/9291
|
|
Gastrointestinal disorders
Gastric Ulcer Haemorrhage
|
0.12%
11/9333
|
0.06%
6/9291
|
|
Gastrointestinal disorders
Duodenal Ulcer Haemorrhage
|
0.11%
10/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Melaena
|
0.11%
10/9333
|
0.03%
3/9291
|
|
Gastrointestinal disorders
Vomiting
|
0.11%
10/9333
|
0.04%
4/9291
|
|
Gastrointestinal disorders
Gastritis
|
0.09%
8/9333
|
0.10%
9/9291
|
|
Gastrointestinal disorders
Upper Gastrointestinal Haemorrhage
|
0.10%
9/9333
|
0.08%
7/9291
|
|
Gastrointestinal disorders
Gastrooesophageal Reflux Disease
|
0.04%
4/9333
|
0.08%
7/9291
|
|
Gastrointestinal disorders
Rectal Haemorrhage
|
0.08%
7/9333
|
0.06%
6/9291
|
|
Gastrointestinal disorders
Dyspepsia
|
0.06%
6/9333
|
0.05%
5/9291
|
|
Gastrointestinal disorders
Haematemesis
|
0.05%
5/9333
|
0.03%
3/9291
|
|
Gastrointestinal disorders
Pancreatitis
|
0.04%
4/9333
|
0.05%
5/9291
|
|
Gastrointestinal disorders
Pancreatitis Acute
|
0.05%
5/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Retroperitoneal Haemorrhage
|
0.05%
5/9333
|
0.03%
3/9291
|
|
Gastrointestinal disorders
Gastric Haemorrhage
|
0.03%
3/9333
|
0.04%
4/9291
|
|
Gastrointestinal disorders
Gastric Ulcer
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Gastritis Erosive
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Haematochezia
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Inguinal Hernia
|
0.04%
4/9333
|
0.04%
4/9291
|
|
Gastrointestinal disorders
Lower Gastrointestinal Haemorrhage
|
0.01%
1/9333
|
0.04%
4/9291
|
|
Gastrointestinal disorders
Nausea
|
0.03%
3/9333
|
0.04%
4/9291
|
|
Gastrointestinal disorders
Anal Haemorrhage
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Gastrointestinal disorders
Diverticulum
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Duodenal Ulcer
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Enteritis
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Gastrointestinal disorders
Gastrointestinal Necrosis
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Haemorrhoidal Haemorrhage
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Gastrointestinal disorders
Peptic Ulcer Haemorrhage
|
0.03%
3/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Peritonitis
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Gastrointestinal disorders
Retroperitoneal Haematoma
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Gastrointestinal disorders
Abdominal Discomfort
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Constipation
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Diverticulum Intestinal
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Diverticulum Intestinal Haemorrhagic
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Duodenitis
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Dysphagia
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Faeces Discoloured
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Gastric Disorder
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Gastritis Haemorrhagic
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Gastroduodenal Haemorrhage
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Ileus Paralytic
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Intestinal Haemorrhage
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Intestinal Ischaemia
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Large Intestine Perforation
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Oesophagitis
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Gastrointestinal disorders
Rectal Polyp
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Small Intestinal Obstruction
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Abdominal Hernia Obstructive
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Anal Fistula
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Appendicitis Perforated
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Ascites
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Colitis Ischaemic
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Colitis Ulcerative
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Colonic Polyp
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Dental Caries
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Diarrhoea Haemorrhagic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Diverticular Perforation
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Diverticulitis Intestinal Haemorrhagic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Enterocolitis Haemorrhagic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Epigastric Discomfort
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Erosive Oesophagitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Faecal Incontinence
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Food Poisoning
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Gastritis Atrophic
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Gastrointestinal Disorder
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Gastrointestinal Pain
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Gastrointestinal Ulcer Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Gingival Bleeding
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Gingivitis Ulcerative
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Haemorrhagic Erosive Gastritis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Haemorrhoids
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Hiatus Hernia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Inguinal Hernia Strangulated
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Intestinal Obstruction
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Intestinal Polyp
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Intra-Abdominal Haemorrhage
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Mallory-Weiss Syndrome
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Mesenteric Artery Embolism
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Mouth Haemorrhage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Oesophageal Food Impaction
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Oesophageal Haemorrhage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Oesophageal Pain
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Oesophageal Varices Haemorrhage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Oesophagitis Haemorrhagic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Pancreatic Disorder
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Pancreatic Haemorrhage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Pancreatitis Chronic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Peptic Ulcer
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Pneumoperitoneum
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Polyp Colorectal
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Proctitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Bronchiectasis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Reflux Oesophagitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Retroperitoneal Fibrosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Small Intestinal Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Small Intestinal Perforation
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Stomach Mass
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Subileus
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Thrombosis Mesenteric Vessel
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Gastrointestinal disorders
Tongue Oedema
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Toothache
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Gastrointestinal disorders
Volvulus
|
0.00%
0/9333
|
0.01%
1/9291
|
|
General disorders
Non-Cardiac Chest Pain
|
1.1%
101/9333
|
1.1%
103/9291
|
|
General disorders
Chest Pain
|
0.58%
54/9333
|
0.68%
63/9291
|
|
General disorders
Death
|
0.23%
21/9333
|
0.33%
31/9291
|
|
General disorders
Sudden Death
|
0.18%
17/9333
|
0.29%
27/9291
|
|
General disorders
Sudden Cardiac Death
|
0.15%
14/9333
|
0.27%
25/9291
|
|
General disorders
Vessel Puncture Site Haematoma
|
0.09%
8/9333
|
0.13%
12/9291
|
|
General disorders
Pyrexia
|
0.11%
10/9333
|
0.05%
5/9291
|
|
General disorders
Multi-Organ Failure
|
0.10%
9/9333
|
0.10%
9/9291
|
|
General disorders
Vessel Puncture Site Haemorrhage
|
0.10%
9/9333
|
0.06%
6/9291
|
|
General disorders
Asthenia
|
0.06%
6/9333
|
0.04%
4/9291
|
|
General disorders
Malaise
|
0.06%
6/9333
|
0.03%
3/9291
|
|
General disorders
General Physical Health Deterioration
|
0.01%
1/9333
|
0.05%
5/9291
|
|
General disorders
Chest Discomfort
|
0.04%
4/9333
|
0.02%
2/9291
|
|
General disorders
Impaired Healing
|
0.01%
1/9333
|
0.04%
4/9291
|
|
General disorders
Oedema Peripheral
|
0.04%
4/9333
|
0.01%
1/9291
|
|
General disorders
Puncture Site Haemorrhage
|
0.04%
4/9333
|
0.01%
1/9291
|
|
General disorders
Cardiac Death
|
0.03%
3/9333
|
0.01%
1/9291
|
|
General disorders
Catheter Site Haemorrhage
|
0.01%
1/9333
|
0.02%
2/9291
|
|
General disorders
Fatigue
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Infections and infestations
Bronchitis Viral
|
0.00%
0/9333
|
0.01%
1/9291
|
|
General disorders
Systemic Inflammatory Response Syndrome
|
0.01%
1/9333
|
0.02%
2/9291
|
|
General disorders
Accidental Death
|
0.01%
1/9333
|
0.00%
0/9291
|
|
General disorders
Alcohol Interaction
|
0.01%
1/9333
|
0.00%
0/9291
|
|
General disorders
Application Site Inflammation
|
0.01%
1/9333
|
0.00%
0/9291
|
|
General disorders
Discomfort
|
0.01%
1/9333
|
0.00%
0/9291
|
|
General disorders
Foaming At Mouth
|
0.01%
1/9333
|
0.00%
0/9291
|
|
General disorders
Gait Disturbance
|
0.00%
0/9333
|
0.01%
1/9291
|
|
General disorders
Generalised Oedema
|
0.01%
1/9333
|
0.00%
0/9291
|
|
General disorders
Hernia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
General disorders
Hypothermia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
General disorders
Inflammation
|
0.00%
0/9333
|
0.01%
1/9291
|
|
General disorders
Injection Site Swelling
|
0.01%
1/9333
|
0.00%
0/9291
|
|
General disorders
Pain
|
0.00%
0/9333
|
0.01%
1/9291
|
|
General disorders
Pelvic Mass
|
0.00%
0/9333
|
0.01%
1/9291
|
|
General disorders
Ulcer Haemorrhage
|
0.01%
1/9333
|
0.01%
1/9291
|
|
General disorders
Unevaluable Event
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Cholecystitis
|
0.08%
7/9333
|
0.11%
10/9291
|
|
Hepatobiliary disorders
Cholelithiasis
|
0.10%
9/9333
|
0.10%
9/9291
|
|
Hepatobiliary disorders
Cholecystitis Acute
|
0.05%
5/9333
|
0.08%
7/9291
|
|
Hepatobiliary disorders
Hepatic Failure
|
0.02%
2/9333
|
0.04%
4/9291
|
|
Hepatobiliary disorders
Bile Duct Stone
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Hepatobiliary disorders
Biliary Colic
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Hepatobiliary disorders
Cholangitis
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Hepatobiliary disorders
Hepatic Cirrhosis
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Hepatobiliary disorders
Jaundice
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Hepatobiliary disorders
Bile Duct Obstruction
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Cholecystitis Chronic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Cholestasis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Gallbladder Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Gallbladder Necrosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Hepatic Function Abnormal
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Hepatitis Toxic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Hepatocellular Injury
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Ischaemic Hepatitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Hepatobiliary disorders
Liver Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Immune system disorders
Anaphylactic Reaction
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Immune system disorders
Anaphylactic Shock
|
0.03%
3/9333
|
0.01%
1/9291
|
|
Immune system disorders
Drug Hypersensitivity
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Immune system disorders
Hypersensitivity
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Immune system disorders
Allergy To Arthropod Bite
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Immune system disorders
Contrast Media Allergy
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Pneumonia
|
0.74%
69/9333
|
1.0%
95/9291
|
|
Infections and infestations
Sepsis
|
0.18%
17/9333
|
0.29%
27/9291
|
|
Infections and infestations
Urinary Tract Infection
|
0.27%
25/9333
|
0.20%
19/9291
|
|
Infections and infestations
Gastroenteritis
|
0.18%
17/9333
|
0.12%
11/9291
|
|
Infections and infestations
Bronchitis
|
0.14%
13/9333
|
0.16%
15/9291
|
|
Infections and infestations
Mediastinitis
|
0.12%
11/9333
|
0.04%
4/9291
|
|
Infections and infestations
Bronchopneumonia
|
0.11%
10/9333
|
0.04%
4/9291
|
|
Infections and infestations
Septic Shock
|
0.05%
5/9333
|
0.11%
10/9291
|
|
Infections and infestations
Cellulitis
|
0.10%
9/9333
|
0.10%
9/9291
|
|
Infections and infestations
Postoperative Wound Infection
|
0.10%
9/9333
|
0.03%
3/9291
|
|
Infections and infestations
Respiratory Tract Infection
|
0.10%
9/9333
|
0.05%
5/9291
|
|
Infections and infestations
Diverticulitis
|
0.08%
7/9333
|
0.09%
8/9291
|
|
Infections and infestations
Wound Infection
|
0.08%
7/9333
|
0.09%
8/9291
|
|
Infections and infestations
Appendicitis
|
0.06%
6/9333
|
0.02%
2/9291
|
|
Infections and infestations
Infection
|
0.01%
1/9333
|
0.05%
5/9291
|
|
Infections and infestations
Lung Infection
|
0.05%
5/9333
|
0.04%
4/9291
|
|
Infections and infestations
Erysipelas
|
0.04%
4/9333
|
0.04%
4/9291
|
|
Infections and infestations
Lower Respiratory Tract Infection
|
0.03%
3/9333
|
0.04%
4/9291
|
|
Infections and infestations
Urosepsis
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Infections and infestations
Cystitis
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Infections and infestations
Endocarditis
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Infections and infestations
Gangrene
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Infections and infestations
Gastrointestinal Infection
|
0.03%
3/9333
|
0.01%
1/9291
|
|
Infections and infestations
Osteomyelitis
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Infections and infestations
Pyelonephritis
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Infections and infestations
Staphylococcal Sepsis
|
0.03%
3/9333
|
0.01%
1/9291
|
|
Infections and infestations
Upper Respiratory Tract Infection
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Infections and infestations
Abscess Limb
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Infections and infestations
Acute Tonsillitis
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Infections and infestations
Anal Abscess
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Infections and infestations
Bacteraemia
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Infections and infestations
Gastroenteritis Caliciviral
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Infections and infestations
Gastroenteritis Viral
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Infections and infestations
Incision Site Infection
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Infections and infestations
Lobar Pneumonia
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Infections and infestations
Localised Infection
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Infections and infestations
Sinusitis
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Infections and infestations
Skin Infection
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Infections and infestations
Staphylococcal Infection
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Infections and infestations
Tooth Abscess
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Infections and infestations
Abdominal Abscess
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Abdominal Wall Infection
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Abscess
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Acquired Immunodeficiency Syndrome
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Acute Sinusitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Arthritis Bacterial
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Arthritis Infective
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Catheter Related Infection
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Catheter Site Infection
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Cholecystitis Infective
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Clostridium Difficile Colitis
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Dengue Fever
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Device Related Infection
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Diarrhoea Infectious
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Endometritis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Enterococcal Infection
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Enterocolitis Infectious
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Febrile Infection
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Gastric Infection
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Gastroenteritis Rotavirus
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Gastroenteritis Salmonella
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Groin Abscess
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Groin Infection
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Haematoma Infection
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Helicobacter Gastritis
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Hepatitis Viral
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Herpes Zoster
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Histoplasmosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Impetigo
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Incision Site Abscess
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Infected Skin Ulcer
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Infective Exacerbation Of Chronic Obstructive Airways Disease
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Infective Tenosynovitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Inguinal Hernia Gangrenous
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Injection Site Cellulitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Intervertebral Discitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Laryngitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Liver Abscess
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Lyme Disease
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Meningitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Necrotising Fasciitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Pancreatic Abscess
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Perineal Abscess
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Pharyngitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Pneumococcal Sepsis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Pneumonia Staphylococcal
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Post Procedural Cellulitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Post Procedural Infection
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Post Procedural Sepsis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Pulmonary Sepsis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Pulmonary Tuberculosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Puncture Site Abscess
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Puncture Site Infection
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Pyelonephritis Acute
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Pyothorax
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Rectal Abscess
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Renal Abscess
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Retroperitoneal Abscess
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Staphylococcal Mediastinitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Sternitis
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Subcutaneous Abscess
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Syphilis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Tooth Infection
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Infections and infestations
Tracheitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Infections and infestations
Tracheobronchitis
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Viral Myocarditis
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Infections and infestations
Viral Pericarditis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Thrombosis In Device
|
0.38%
35/9333
|
0.61%
57/9291
|
|
Injury, poisoning and procedural complications
Post Procedural Haemorrhage
|
0.60%
56/9333
|
0.51%
47/9291
|
|
Injury, poisoning and procedural complications
In-Stent Coronary Artery Restenosis
|
0.38%
35/9333
|
0.27%
25/9291
|
|
Injury, poisoning and procedural complications
Vascular Pseudoaneurysm
|
0.16%
15/9333
|
0.25%
23/9291
|
|
Injury, poisoning and procedural complications
In-Stent Arterial Restenosis
|
0.11%
10/9333
|
0.13%
12/9291
|
|
Injury, poisoning and procedural complications
Coronary Artery Restenosis
|
0.04%
4/9333
|
0.10%
9/9291
|
|
Injury, poisoning and procedural complications
Femur Fracture
|
0.03%
3/9333
|
0.08%
7/9291
|
|
Injury, poisoning and procedural complications
Post Procedural Haematoma
|
0.08%
7/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Fall
|
0.01%
1/9333
|
0.05%
5/9291
|
|
Injury, poisoning and procedural complications
Femoral Neck Fracture
|
0.03%
3/9333
|
0.05%
5/9291
|
|
Injury, poisoning and procedural complications
Postpericardiotomy Syndrome
|
0.05%
5/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Hip Fracture
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Lower Limb Fracture
|
0.00%
0/9333
|
0.04%
4/9291
|
|
Injury, poisoning and procedural complications
Post Procedural Complication
|
0.04%
4/9333
|
0.04%
4/9291
|
|
Injury, poisoning and procedural complications
Subdural Haematoma
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Wrist Fracture
|
0.04%
4/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Hand Fracture
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Head Injury
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Injury, poisoning and procedural complications
Injury
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Injury, poisoning and procedural complications
Operative Haemorrhage
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Injury, poisoning and procedural complications
Postoperative Thoracic Procedure Complication
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Injury, poisoning and procedural complications
Postoperative Wound Complication
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Injury, poisoning and procedural complications
Procedural Pain
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Subcutaneous Haematoma
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Wound Dehiscence
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Alcohol Poisoning
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Clavicle Fracture
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Concussion
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Facial Bones Fracture
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Foot Fracture
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Graft Thrombosis
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Humerus Fracture
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Injury, poisoning and procedural complications
Ligament Rupture
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Limb Injury
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Limb Traumatic Amputation
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Overdose
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Injury, poisoning and procedural complications
Postoperative Thrombosis
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Procedural Hypotension
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Injury, poisoning and procedural complications
Renal Injury
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Cerebral Atrophy
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Cerebral Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Bone Neoplasm Malignant
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Brain Cancer Metastatic
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Breast Cancer Metastatic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Bronchial Neoplasm
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Carcinoid Tumour Of The Caecum
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Carcinoid Tumour Of The Duodenum
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Chronic Leukaemia
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Colon Adenoma
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Colorectal Cancer
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Endometrial Cancer
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Cerebrovascular Insufficiency
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Extranodal Marginal Zone B-Cell Lymphoma (Malt Type)
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Gastric Neoplasm
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Gastrointestinal Carcinoma
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Glioblastoma
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Haemangioma Of Liver
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Hepatic Neoplasm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Intestinal Adenocarcinoma
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lip And/Or Oral Cavity Cancer
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lung Cancer Metastatic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lymphangiosis Carcinomatosa
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lymphocytic Lymphoma
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Malignant Pleural Effusion
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Meningioma
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Metastases To Central Nervous System
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Metastases To Lymph Nodes
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Myelodysplastic Syndrome
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Neoplasm Malignant
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Neoplasm Prostate
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Nipple Neoplasm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Pancreatic Carcinoma Recurrent
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Pleural Mesothelioma
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Polycythaemia Vera
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Prostate Cancer Metastatic
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Prostate Cancer Recurrent
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Orthostatic Hypotension
|
0.04%
4/9333
|
0.03%
3/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Prostatic Adenoma
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Rectal Cancer Metastatic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Renal Cancer Metastatic
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Retroperitoneal Neoplasm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Small Cell Lung Cancer Metastatic
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Small Cell Lung Cancer Stage Unspecified
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Spinal Cord Neoplasm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Squamous Cell Carcinoma
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Testis Cancer
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Thyroid Adenoma
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Thyroid Cancer Metastatic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Thyroid Neoplasm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Tongue Neoplasm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Transitional Cell Carcinoma
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Uterine Leiomyoma
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Cerebrovascular Accident
|
0.80%
75/9333
|
0.54%
50/9291
|
|
Nervous system disorders
Syncope
|
0.34%
32/9333
|
0.32%
30/9291
|
|
Nervous system disorders
Ischaemic Stroke
|
0.21%
20/9333
|
0.30%
28/9291
|
|
Nervous system disorders
Transient Ischaemic Attack
|
0.20%
19/9333
|
0.25%
23/9291
|
|
Nervous system disorders
Dizziness
|
0.14%
13/9333
|
0.08%
7/9291
|
|
Nervous system disorders
Cerebral Haemorrhage
|
0.10%
9/9333
|
0.03%
3/9291
|
|
Nervous system disorders
Cerebral Infarction
|
0.08%
7/9333
|
0.09%
8/9291
|
|
Nervous system disorders
Presyncope
|
0.09%
8/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Haemorrhagic Stroke
|
0.06%
6/9333
|
0.08%
7/9291
|
|
Nervous system disorders
Headache
|
0.06%
6/9333
|
0.03%
3/9291
|
|
Nervous system disorders
Haemorrhage Intracranial
|
0.05%
5/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Paraesthesia
|
0.05%
5/9333
|
0.04%
4/9291
|
|
Nervous system disorders
Hemiparesis
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Loss Of Consciousness
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Parkinson's Disease
|
0.01%
1/9333
|
0.04%
4/9291
|
|
Nervous system disorders
Subarachnoid Haemorrhage
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Syncope Vasovagal
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Carotid Artery Stenosis
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Convulsion
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Nervous system disorders
Depressed Level Of Consciousness
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Nervous system disorders
Hypoaesthesia
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Nervous system disorders
Hypotonia
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Migraine
|
0.03%
3/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Altered State Of Consciousness
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Brain Stem Ischaemia
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Cerebral Ischaemia
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Cerebrovascular Disorder
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Dementia
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Encephalopathy
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Hypoxic Encephalopathy
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Nervous system disorders
Neuralgia
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Partial Seizures
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Balance Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Brain Oedema
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Brain Stem Infarction
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Brain Stem Stroke
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Carotid Artery Disease
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Carotid Artery Occlusion
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Carotid Artery Thrombosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Carotid Sinus Syndrome
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Cervicobrachial Syndrome
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Cognitive Disorder
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Complex Partial Seizures
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Diabetic Hyperosmolar Coma
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Diabetic Neuropathy
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Dysphasia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Embolic Cerebral Infarction
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Encephalitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Epilepsy
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Extrapyramidal Disorder
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Facial Paresis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Febrile Convulsion
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Haemorrhagic Cerebral Infarction
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Hepatic Encephalopathy
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Intracranial Haematoma
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Ischaemic Cerebral Infarction
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Lacunar Infarction
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Lumbar Radiculopathy
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Mental Impairment
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Myelitis Transverse
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Narcolepsy
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Parkinsonism
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Phrenic Nerve Paralysis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Post Herpetic Neuralgia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Progressive Supranuclear Palsy
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Psychomotor Hyperactivity
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Sciatica
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Speech Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Spinal Cord Compression
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Spinal Cord Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Thalamus Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Thrombotic Stroke
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Vascular Encephalopathy
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Nervous system disorders
Vertebrobasilar Insufficiency
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Vith Nerve Paralysis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Nervous system disorders
Vocal Cord Paresis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Anxiety
|
0.10%
9/9333
|
0.06%
6/9291
|
|
Psychiatric disorders
Depression
|
0.10%
9/9333
|
0.08%
7/9291
|
|
Psychiatric disorders
Confusional State
|
0.04%
4/9333
|
0.02%
2/9291
|
|
Psychiatric disorders
Suicide Attempt
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Psychiatric disorders
Acute Stress Disorder
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Agitation
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Alcohol Abuse
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Alcoholism
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Anxiety Disorder
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Completed Suicide
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Delirium
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Drug Abuse
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Insomnia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Mania
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Mental Disorder
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Nervousness
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Neurosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Panic Attack
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Post-Traumatic Amnestic Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Psychotic Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Schizophrenia, Paranoid Type
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Sleep Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Suicidal Ideation
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Psychiatric disorders
Tension
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Psychiatric disorders
Transient Psychosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Renal Failure Acute
|
0.36%
34/9333
|
0.27%
25/9291
|
|
Renal and urinary disorders
Renal Failure
|
0.27%
25/9333
|
0.26%
24/9291
|
|
Renal and urinary disorders
Haematuria
|
0.16%
15/9333
|
0.11%
10/9291
|
|
Renal and urinary disorders
Renal Failure Chronic
|
0.08%
7/9333
|
0.08%
7/9291
|
|
Renal and urinary disorders
Urinary Retention
|
0.03%
3/9333
|
0.08%
7/9291
|
|
Renal and urinary disorders
Renal Impairment
|
0.05%
5/9333
|
0.04%
4/9291
|
|
Renal and urinary disorders
Calculus Ureteric
|
0.02%
2/9333
|
0.04%
4/9291
|
|
Renal and urinary disorders
Calculus Urinary
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Renal and urinary disorders
Haemorrhage Urinary Tract
|
0.03%
3/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Nephrolithiasis
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Renal and urinary disorders
Nephropathy Toxic
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Renal and urinary disorders
Renal Artery Stenosis
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Renal and urinary disorders
Renal Colic
|
0.03%
3/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Azotaemia
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Urinary Bladder Haemorrhage
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Urinary Bladder Polyp
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Renal and urinary disorders
Anuria
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Bladder Mass
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Bladder Prolapse
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Bladder Tamponade
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Calculus Bladder
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Calculus Urethral
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Cystitis Haemorrhagic
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Cystitis Noninfective
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Dysuria
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Glomerulonephritis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Glomerulonephritis Membranous
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Glomerulonephritis Minimal Lesion
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Hydronephrosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Nephritis Autoimmune
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Nephrotic Syndrome
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Obstructive Uropathy
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Oliguria
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Renal Artery Thrombosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Renal Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Renal Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Renal Mass
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Urethral Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Renal and urinary disorders
Urinary Incontinence
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Renal and urinary disorders
Urinary Tract Obstruction
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Reproductive system and breast disorders
Benign Prostatic Hyperplasia
|
0.05%
5/9333
|
0.03%
3/9291
|
|
Reproductive system and breast disorders
Epididymitis
|
0.03%
3/9333
|
0.01%
1/9291
|
|
Reproductive system and breast disorders
Prostatitis
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Reproductive system and breast disorders
Balanitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Reproductive system and breast disorders
Cervical Dysplasia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Reproductive system and breast disorders
Menometrorrhagia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Reproductive system and breast disorders
Ovarian Cyst
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Reproductive system and breast disorders
Prostatic Haemorrhage
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Reproductive system and breast disorders
Prostatism
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Reproductive system and breast disorders
Spermatocele
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Reproductive system and breast disorders
Uterine Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Reproductive system and breast disorders
Vaginal Haemorrhage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Dyspnoea
|
0.80%
75/9333
|
0.54%
50/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Oedema
|
0.35%
33/9333
|
0.57%
53/9291
|
|
Respiratory, thoracic and mediastinal disorders
Acute Pulmonary Oedema
|
0.21%
20/9333
|
0.34%
32/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Embolism
|
0.33%
31/9333
|
0.22%
20/9291
|
|
Respiratory, thoracic and mediastinal disorders
Chronic Obstructive Pulmonary Disease
|
0.24%
22/9333
|
0.18%
17/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pleural Effusion
|
0.23%
21/9333
|
0.20%
19/9291
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory Failure
|
0.17%
16/9333
|
0.17%
16/9291
|
|
Respiratory, thoracic and mediastinal disorders
Epistaxis
|
0.16%
15/9333
|
0.10%
9/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pneumothorax
|
0.03%
3/9333
|
0.10%
9/9291
|
|
Respiratory, thoracic and mediastinal disorders
Haemoptysis
|
0.08%
7/9333
|
0.09%
8/9291
|
|
Respiratory, thoracic and mediastinal disorders
Acute Respiratory Failure
|
0.05%
5/9333
|
0.06%
6/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pneumonia Aspiration
|
0.03%
3/9333
|
0.06%
6/9291
|
|
Respiratory, thoracic and mediastinal disorders
Asthma
|
0.05%
5/9333
|
0.03%
3/9291
|
|
Respiratory, thoracic and mediastinal disorders
Hydrothorax
|
0.02%
2/9333
|
0.05%
5/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Congestion
|
0.05%
5/9333
|
0.03%
3/9291
|
|
Respiratory, thoracic and mediastinal disorders
Acute Respiratory Distress Syndrome
|
0.04%
4/9333
|
0.03%
3/9291
|
|
Respiratory, thoracic and mediastinal disorders
Aspiration
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Respiratory, thoracic and mediastinal disorders
Cough
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Dyspnoea Exertional
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Respiratory, thoracic and mediastinal disorders
Haemothorax
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pleuritic Pain
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pneumonitis
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Mass
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory Arrest
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Respiratory, thoracic and mediastinal disorders
Bronchospasm
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Hyperventilation
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Lung Disorder
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pleurisy
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Haemorrhage
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Respiratory, thoracic and mediastinal disorders
Alveolitis Fibrosing
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Apnoea
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Atelectasis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Brain Hypoxia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Bronchial Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Bronchial Obstruction
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Bronchitis Chronic
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Dyspnoea Paroxysmal Nocturnal
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Emphysema
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Hypoxia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Interstitial Lung Disease
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Laryngeal Leukoplakia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Laryngeal Oedema
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Laryngeal Stenosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Laryngospasm
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Lower Respiratory Tract Inflammation
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Lung Consolidation
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Mediastinal Haematoma
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Mediastinal Haemorrhage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Nasal Polyps
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Nocturnal Dyspnoea
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Alveolar Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Fibrosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Pulmonary Haematoma
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory Distress
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Respiratory Tract Haemorrhage
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Rhinorrhoea
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Systemic Sclerosis Pulmonary
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Tachypnoea
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Thoracic Haemorrhage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Tonsillar Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Respiratory, thoracic and mediastinal disorders
Tracheal Stenosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Vocal Cord Polyp
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Wegener's Granulomatosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Respiratory, thoracic and mediastinal disorders
Wheezing
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Dermatitis Allergic
|
0.01%
1/9333
|
0.06%
6/9291
|
|
Skin and subcutaneous tissue disorders
Angioedema
|
0.03%
3/9333
|
0.04%
4/9291
|
|
Skin and subcutaneous tissue disorders
Rash
|
0.04%
4/9333
|
0.03%
3/9291
|
|
Skin and subcutaneous tissue disorders
Urticaria
|
0.03%
3/9333
|
0.04%
4/9291
|
|
Skin and subcutaneous tissue disorders
Pruritus
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Skin and subcutaneous tissue disorders
Skin Ulcer
|
0.03%
3/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Decubitus Ulcer
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Hyperhidrosis
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Skin Necrosis
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Alopecia
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Blister
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Dermatitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Dermatomyositis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Dry Gangrene
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Eczema Nummular
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Erythema
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Hypoaesthesia Facial
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Increased Tendency To Bruise
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Leukocytoclastic Vasculitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Pruritus Generalised
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Rash Erythematous
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Rash Generalised
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Skin and subcutaneous tissue disorders
Seborrhoeic Dermatitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Skin Inflammation
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Surgical and medical procedures
Cardiac Pacemaker Insertion
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Surgical and medical procedures
Coronary Artery Bypass
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Surgical and medical procedures
Implantable Defibrillator Insertion
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Surgical and medical procedures
Leg Amputation
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Surgical and medical procedures
Thoracic Cavity Drainage
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Hypertension
|
0.18%
17/9333
|
0.26%
24/9291
|
|
Vascular disorders
Hypotension
|
0.19%
18/9333
|
0.23%
21/9291
|
|
Vascular disorders
Hypertensive Crisis
|
0.08%
7/9333
|
0.13%
12/9291
|
|
Vascular disorders
Peripheral Ischaemia
|
0.11%
10/9333
|
0.08%
7/9291
|
|
Vascular disorders
Haematoma
|
0.03%
3/9333
|
0.09%
8/9291
|
|
Vascular disorders
Aortic Aneurysm
|
0.00%
0/9333
|
0.08%
7/9291
|
|
Vascular disorders
Shock
|
0.08%
7/9333
|
0.03%
3/9291
|
|
Vascular disorders
Deep Vein Thrombosis
|
0.06%
6/9333
|
0.06%
6/9291
|
|
Vascular disorders
Intermittent Claudication
|
0.06%
6/9333
|
0.06%
6/9291
|
|
Vascular disorders
Accelerated Hypertension
|
0.01%
1/9333
|
0.05%
5/9291
|
|
Vascular disorders
Arterial Thrombosis Limb
|
0.05%
5/9333
|
0.04%
4/9291
|
|
Vascular disorders
Peripheral Arterial Occlusive Disease
|
0.04%
4/9333
|
0.05%
5/9291
|
|
Vascular disorders
Peripheral Vascular Disorder
|
0.05%
5/9333
|
0.03%
3/9291
|
|
Vascular disorders
Aortic Dissection
|
0.02%
2/9333
|
0.04%
4/9291
|
|
Vascular disorders
Arterial Thrombosis
|
0.01%
1/9333
|
0.04%
4/9291
|
|
Vascular disorders
Circulatory Collapse
|
0.04%
4/9333
|
0.00%
0/9291
|
|
Vascular disorders
Aortic Stenosis
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Vascular disorders
Arteriosclerosis
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Vascular disorders
Femoral Artery Aneurysm
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Vascular disorders
Haemorrhage
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Vascular disorders
Hypertensive Emergency
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Vascular disorders
Hypovolaemic Shock
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Vascular disorders
Thrombophlebitis
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Vascular disorders
Venous Thrombosis
|
0.02%
2/9333
|
0.03%
3/9291
|
|
Vascular disorders
Aortic Aneurysm Rupture
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Vascular disorders
Arterial Occlusive Disease
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Vascular disorders
Arteriosclerosis Obliterans
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Vascular disorders
Arteriovenous Fistula
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Vascular disorders
Artery Dissection
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Vascular disorders
Cardiovascular Insufficiency
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Vascular disorders
Femoral Artery Occlusion
|
0.02%
2/9333
|
0.02%
2/9291
|
|
Vascular disorders
Iliac Artery Stenosis
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Vascular disorders
Leriche Syndrome
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Vascular disorders
Shock Haemorrhagic
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Vascular disorders
Thrombophlebitis Superficial
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Vascular disorders
Thrombosis
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Vascular disorders
Venous Thrombosis Limb
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Vascular disorders
Aneurysm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Aneurysm Ruptured
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Angiodysplasia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Aortic Dilatation
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Vascular disorders
Arterial Disorder
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Arterial Rupture
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Arteritis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Bleeding Varicose Vein
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Blood Pressure Inadequately Controlled
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Embolism
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Embolism Venous
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Extremity Necrosis
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Vascular disorders
Femoral Arterial Stenosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Haemodynamic Instability
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Iliac Artery Occlusion
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Iliac Artery Thrombosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Peripheral Artery Aneurysm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Peripheral Artery Dissection
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Peripheral Embolism
|
0.01%
1/9333
|
0.01%
1/9291
|
|
Vascular disorders
Phlebitis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Reperfusion Injury
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Subclavian Artery Stenosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Subclavian Artery Thrombosis
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Vascular disorders
Subclavian Vein Thrombosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Vascular Occlusion
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Vasculitis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Vena Cava Thrombosis
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Vascular disorders
Venous Insufficiency
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Skin and subcutaneous tissue disorders
Wound Haemorrhage
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Colon Cancer
|
0.11%
10/9333
|
0.03%
3/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lung Neoplasm Malignant
|
0.06%
6/9333
|
0.11%
10/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Breast Cancer
|
0.03%
3/9333
|
0.10%
9/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Prostate Cancer
|
0.06%
6/9333
|
0.09%
8/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lung Neoplasm
|
0.08%
7/9333
|
0.05%
5/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Bladder Cancer
|
0.02%
2/9333
|
0.06%
6/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Colon Neoplasm
|
0.01%
1/9333
|
0.05%
5/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Renal Neoplasm
|
0.05%
5/9333
|
0.03%
3/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Bladder Neoplasm
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Brain Neoplasm
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Bronchial Carcinoma
|
0.01%
1/9333
|
0.03%
3/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Gastric Cancer
|
0.03%
3/9333
|
0.03%
3/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Metastases To Liver
|
0.00%
0/9333
|
0.03%
3/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Rectal Cancer
|
0.03%
3/9333
|
0.02%
2/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Bladder Transitional Cell Carcinoma
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Chronic Lymphocytic Leukaemia
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Gastrointestinal Neoplasm
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Hepatic Cancer Metastatic
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Laryngeal Cancer
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lung Adenocarcinoma
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Lymphoma
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Malignant Melanoma
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Metastases To Bone
|
0.01%
1/9333
|
0.02%
2/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Metastases To Lung
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Metastatic Neoplasm
|
0.02%
2/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Oesophageal Carcinoma
|
0.00%
0/9333
|
0.02%
2/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Ovarian Cancer
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Renal Cancer
|
0.02%
2/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Abdominal Neoplasm
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Acute Myeloid Leukaemia
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Adenocarcinoma
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Adenocarcinoma Pancreas
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
B-Cell Lymphoma
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Benign Duodenal Neoplasm
|
0.01%
1/9333
|
0.00%
0/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Benign Neoplasm Of Skin
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Benign Uterine Neoplasm
|
0.00%
0/9333
|
0.01%
1/9291
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Bladder Cancer Recurrent
|
0.00%
0/9333
|
0.01%
1/9291
|
Other adverse events
| Measure |
TICAGRELOR
Ticagrelor 90 mg twice daily dose (BD)
|
CLOPIDOGREL
Clopidogrel 75 mg once daily dose (ODD)
|
|---|---|---|
|
Nervous system disorders
Headache
|
6.7%
621/9333
|
6.1%
565/9291
|
|
Respiratory, thoracic and mediastinal disorders
Dyspnoea
|
11.9%
1106/9333
|
6.7%
623/9291
|
|
Respiratory, thoracic and mediastinal disorders
Epistaxis
|
6.1%
566/9333
|
3.4%
317/9291
|
|
Respiratory, thoracic and mediastinal disorders
Cough
|
5.3%
490/9333
|
5.0%
467/9291
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee An Investigator agrees to provide a copy of the publication to AstraZeneca (AZ) for review at least 60 days in advance of submission for publication. Investigators in multicenter (MC) studies agree to postpone MC publications until the earlier of the date of the first AZ-authorized MC publication or a period up to 18 months from study completion at all sites.
- Publication restrictions are in place
Restriction type: OTHER